3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
26
Pancreatic Neoplasms
11
Stomach Neoplasms
10
Rectal Neoplasms
10
Colonic Neoplasms
10
Esophageal Neoplasms
8
Adenocarcinoma Of Esophagus
8
Neoplasm Metastasis
6
Urinary Bladder Neoplasms
5
Neoplasms
5
Cholangiocarcinoma
5
Carcinoma, Non-Small-Cell Lung
5
Adenocarcinoma
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Squamous Cell Carcinoma of Head and Neck
3
Esophageal Squamous Cell Carcinoma
3
Endometrial Neoplasms
3
Carcinoma, Hepatocellular
3
Ovarian Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Gastrointestinal Neoplasms
2
Gallbladder Neoplasms
2
Carcinoma
2
Biliary Tract Neoplasms
2
Uterine Cervical Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Interventions
Specimen Handling
3
pembrolizumab
2
Magnetic Resonance Spectroscopy
2
Doxorubicin
2
Biopsy
2
talimogene laherparepvec
1
peposertib
1
liposomal doxorubicin
1
fludarabine
1
aldesleukin
1
X-Rays
1
Radiotherapy
1
Radiation
1
Nivolumab
1
Ipilimumab
1
Histamine H2 Antagonists
1
Famotidine
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Histiocytoma, Malignant Fibrous
×
Fluorouracil
×
30 days
×
Clear all
No trials found.